Lung Cancer

After Donna Rigby visited the emergency department at Hackensack Meridian Jersey Shore University Medical Center, tests showed stage 2 lung cancer.

Lung squamous cell carcinoma starts in airway lining cells; treatment depends on stage, from surgery to systemic therapies, with side effects to monitor.

FDA granted breakthrough therapy designation to zoldonrasib for previously treated KRAS G12D-mutated non-small cell lung cancer.

From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung cancer care and awareness.

Wendy Brooks, a survivor of extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, highlight the role of self-advocacy.

Early trial data suggest Olvi-Vec may shrink or control cancer after platinum therapy, with safety signals in small cell and non-small cell lung cancer.

The EVEREST-2 study has reported the first complete response to CAR-T cell therapy in a patient with non-small cell lung cancer.

CURE spoke with an expert about smoking-related stigmas often faced by patients with lung cancer.

CURE spoke with an expert about why a support system is crucial for patients with lung cancer.

Ceralasertib plus Imfinzi failed to improve overall survival versus docetaxel in a phase 3 study of previously treated non-small cell lung cancer.

CURE spoke with a clinical psychologist about the stigmas often faced by patients with lung cancer.

The FDA has granted approval to Rybrevant Faspro, the first and only subcutaneous therapy for EGFR-mutated non-small cell lung cancer.

The FDA granted orphan drug designation to GSK’227, now known as risvutatug rezetecan, for the treatment of small-cell lung cancer.

Wendy and Larry Brooks share their journey with small cell lung cancer, emphasizing the importance of screening, as well as advocacy for patients and caregivers.

As I reflect on my lung cancer journey, I look back to the 2018 holiday season, feeling comfortable and at peace.

Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to current screening gaps.

Dr. Thomas Marron explains how therapeutic vaccines differ from preventative vaccines in lung cancer care.

This guide explains how squamous cell lung cancer is diagnosed and treated at each stage to help patients talk openly with their oncology team.

Dr. Girindra Raval sat down for an interview with CURE to discuss what patients with EGFR-mutated lung cancer should know about their treatment options.

In November 2025, the FDA issued multiple oncology approvals that expanded treatment access for patients with breast, lung, blood and solid tumor cancers.

Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer.

This guide explains diagnosis, staging, molecular testing and treatment options for non-small cell lung cancer to help patients prepare informed questions.

CURE sat down with Dr. Daniel J. Boffa to discuss the current treatment landscape of lung cancer care in recognition of Lung Cancer Awareness Month.

Dr. Lanyi Nora Chen, sat down for a live interview with CURE, in which, she shares her advice for newly diagnosed patients with lung cancer.

Bernadette’s strength and optimism lifted me through my own cancer journey and reminded me how much one person’s compassion can change how I move through each day.